Ozoralizumab (Anti-TNF-α)
Product Specifications
CAS Number
1167985-17-2
Synonyms
ATN-103
Target
TNF-alpha
Applications
Apoptosis
Additionnal Information
Ozoralizumab is a humanized trivalent, bispecific NANOBODY® targeting TNFα with two anti-TNFα domains and an anti-HSA domain. It demonstrates strong anti-arthritis efficacy in human TNF transgenic mice, effective both at arthritis onset and during secondary failure of anti-TNFα IgG therapy. M.W 38.44 kDa.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682227-100 1x 100 µL
GFAP (Astrocyte & Neural Stem Cell Marker) (rASTRO/789), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401884-100 1x 100 µL
Thymidylate Synthase (5-FU Resistance Marker) (TYMS/1884), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040848-100 1x 100 µL
CD31 / PECAM-1 (C31.10), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details